GlassScriptPhysician profile
Alexander Dane
NPI 1649619982
$100,108.21
in general payments reported to CMS, 2019-2025
24 companies · $27K in 2025
The $27K reported for 2025 was more than what 95% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34K · 2020: $17K · 2021: $11K · 2022: $480 · 2023: $639 · 2024: $10K · 2025: $27K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $17K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,960 · Consulting Fee: $7,500 · Food and Beverage: $3,395 · Travel and Lodging: $1,867.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $17,280.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,960.00 |
| Consulting Fee | $7,500.00 |
| Food and Beverage | $3,394.53 |
| Travel and Lodging | $1,866.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $49,012.89 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $33,662.64 | 2021-2025 | Odomzo, Blu-U |
| Pfizer INC. | $6,008.39 | 2019-2020 | |
| Almirall LLC | $5,307.99 | 2019 | |
| Vertical Pharmaceuticals, LLC | $2,280.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $1,072.80 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $397.63 | 2022-2025 | Dupixent, Libtayo |
| Leo Pharma INC. | $290.70 | 2019 | |
| Genentech USA, INC. | $269.52 | 2021-2024 | Erivedge |
| Abbvie INC. | $208.80 | 2021-2025 | |
| Microaire Surgical Instruments LLC | $207.92 | 2025 | |
| Allergan, INC. | $186.66 | 2019 | |
| Incyte Corporation | $171.36 | 2022-2023 | Opzelura |
| Journey Medical Corporation | $169.41 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $148.70 | 2024 | Sotyktu |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $140.01 | 2020-2023 | Otezla |
| Revance Therapeutics, INC. | $135.39 | 2025 | Daxi, Daxxify |
| Genzyme Corporation | $131.72 | 2021-2022 | |
| Kerecis Limited | $112.10 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Marigen |
| Organogenesis INC. | $90.17 | 2021-2025 | Puraply Wound Matrix |
| Smith+Nephew, INC. | $60.24 | 2022-2024 | Grafix Pl, Pico 14 |
| Biowound Solutions, INC. | $20.21 | 2025 | Bio-Connekt |
| Lilly USA, LLC | $13.87 | 2021 | |
| Biofrontera INC. | $9.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Dane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.